Atea Pharmaceuticals, Inc.
AVIR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001593899
No open-market purchases or sales by Atea Pharmaceuticals, Inc. insiders were filed in the last 90 days; 124 institutions reported holding it in 13F filings for Q2 2026, worth $276.4M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Atea Pharmaceuticals, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 128
- +5 vs. Q1 2022
- Shares held
- 57.5M
- +2.69M (+4.9%) vs. Q1 2022
- Total value
- $408.7M
- +$13.2M (+3.3%) vs. Q1 2022
- New holders
- 22
- 38 more added
- Sold out
- 17
- 42 more reduced
4 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AVIR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 124 | $276.4M |
| Q1 2026 | 127 | $322.8M |
| Q4 2025 | 111 | $203.5M |
| Q3 2025 | 115 | $154.2M |
| Q2 2025 | 107 | $189.7M |
| Q1 2025 | 104 | $158.3M |
| Q4 2024 | 107 | $188.7M |
| Q3 2024 | 108 | $194.0M |
| Q2 2024 | 105 | $187.7M |
| Q1 2024 | 113 | $219.6M |
| Q4 2023 | 108 | $168.3M |
| Q3 2023 | 119 | $170.6M |
| Q2 2023 | 133 | $213.3M |
| Q1 2023 | 131 | $190.2M |
| Q4 2022 | 131 | $278.1M |
| Q3 2022 | 126 | $326.8M |
| Q2 2022 | 128 | $408.7M |
| Q1 2022 | 127 | $396.6M |
| Q4 2021 | 143 | $479.2M |
| Q3 2021 | 142 | $1.99B |
| Q2 2021 | 104 | $1.27B |
| Q1 2021 | 82 | $3.20B |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Atea Pharmaceuticals, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Manufacturers Life Insurance Company, The | 220,308 | $1.56M | 0.00% | −38,347−14.8% | Reduced |
| Goldman Sachs Group Inc | 227,220 | $1.61M | 0.00% | +25,527+12.7% | Added |
| Citadel Advisors LLC | 259,054 | $1.84M | 0.00% | −1,295,171−83.3% | Reduced |
| Jupiter Asset Management Ltd | 263,056 | $1.86M | 0.03% | −7,484−2.8% | Reduced |
| Voloridge Investment Management, LLC | 265,365 | $1.88M | 0.01% | −549,912−67.5% | Reduced |
| Deutsche Bank AG | 266,578 | $1.89M | 0.00% | +19,784+8.0% | Added |
| Bank of New York Mellon Corp | 270,044 | $1.92M | 0.00% | −6,682−2.4% | Reduced |
| Nuveen Asset Management, LLC | 270,163 | $1.92M | 0.00% | +17,150+6.8% | Added |
| Banque Pictet & Cie SA | 345,077 | $2.45M | 0.02% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 347,612 | $2.47M | 0.06% | +320,912+1,201.9% | Added |
| Prudential Financial Inc | 379,335 | $2.69M | 0.00% | −67,780−15.2% | Reduced |
| Morgan Stanley | 392,516 | $2.79M | 0.00% | −36,105−8.4% | Reduced |
| Charles Schwab Investment Management Inc | 427,721 | $3.04M | 0.00% | +13,124+3.2% | Added |
| Jacobs Levy Equity Management, Inc | 432,438 | $3.07M | 0.02% | +278,833+181.5% | Added |
| Renaissance Technologies LLC | 663,000 | $4.71M | 0.01% | −502,000−43.1% | Reduced |
| Northern Trust Corp | 693,126 | $4.92M | 0.00% | +133,106+23.8% | Added |
| Acadian Asset Management LLC | 714,422 | $5.07M | 0.03% | −138,154−16.2% | Reduced |
| Geode Capital Management, LLC | 1,161,424 | $8.25M | 0.00% | +132,664+12.9% | Added |
| Cormorant Asset Management, LP | 1,547,181 | $11.0M | 0.85% | 00.0% | Unchanged |
| K2 Principal Fund, L.P. | 1,606,059 | $11.4M | 1.94% | +1,606,059 | New |
| Balyasny Asset Management LLC | 1,799,507 | $12.8M | 0.05% | +1,788,546+16,317.4% | Added |
| State Street Corp | 1,803,368 | $12.8M | 0.00% | −68,706−3.7% | Reduced |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $17.6M | 2.07% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 3,588,131 | $25.5M | 0.07% | +1,536,799+74.9% | Added |
| EcoR1 Capital, LLC | 6,340,639 | $45.0M | 1.57% | 00.0% | Unchanged |
| Vanguard Group Inc | 7,180,285 | $51.0M | 0.00% | +451,082+6.7% | Added |
| BlackRock Inc. | 7,407,542 | $52.6M | 0.00% | +782,849+11.8% | Added |
| FMR LLC | 12,539,475 | $89.0M | 0.01% | −40,316−0.3% | Reduced |
| PDT Partners, LLC | 0 | $0 | 0.00% | −224,660−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −117,345−100.0% | Sold out |
| Schroder Investment Management Group | 0 | $0 | 0.00% | −104,789−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −96,049−100.0% | Sold out |
| TD Asset Management Inc | 0 | $0 | 0.00% | −50,853−100.0% | Sold out |
| Capital Fund Management S.A. | 0 | $0 | 0.00% | −35,565−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −23,139−100.0% | Sold out |
| Rafferty Asset Management, LLC | 0 | $0 | 0.00% | −15,774−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −11,717−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −11,487−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −10,800−100.0% | Sold out |
| Jefferies Group LLC | 0 | $0 | 0.00% | −7,500−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −4,700−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −4,232−100.0% | Sold out |
| Federation des caisses Desjardins du Quebec | 0 | $0 | 0.00% | −700−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −207−100.0% | Sold out |
| American Portfolios Advisors | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| IndexIQ Advisors LLC | – | – | – | – | Not filed |
| Parametric Portfolio Associates LLC | – | – | – | – | Not filed |
| Virginia Retirement Systems Et Al | – | – | – | – | Not filed |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |